| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.2M | +0.0% |
| R&D Expense | $30.9M | -48.2% |
| SG&A Expense | $23.7M | -5.0% |
| Operating Income | -$59.0M | +21.8% |
| Pre-tax Income | -$49.1M | +28.2% |
| Income Tax | $152K | +193.8% |
| Net Income | -$49.2M | +27.8% |
| EPS (Basic) | -$1.02 | +37.4% |
| EPS (Diluted) | -$1.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.4M | -67.1% |
| Short-term Investments | $85.0M | +52.9% |
| Current Assets | $127.2M | -28.8% |
| Total Assets | $141.5M | -26.3% |
| Current Liabilities | $10.8M | -24.1% |
| Total Liabilities | $15.6M | -30.3% |
| Stockholders' Equity | $125.9M | -25.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.0M | +42.3% |
| Capital Expenditures | $414K | +0.0% |
| Investing Cash Flow | -$34.9M | -154.4% |
| Financing Cash Flow | $76.0M | +0.0% |
| Free Cash Flow | -$46.4M | +42.1% |
| +37.4% |